Prosecution Insights
Last updated: April 19, 2026
Application No. 17/478,447

DIGITAL AND USER INTERFACES FOR ANALYTE MONITORING SYSTEMS

Final Rejection §103
Filed
Sep 17, 2021
Examiner
ORTEGA, MARTIN NATHAN
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Abbott Laboratories
OA Round
6 (Final)
19%
Grant Probability
At Risk
7-8
OA Rounds
3y 7m
To Grant
56%
With Interview

Examiner Intelligence

Grants only 19% of cases
19%
Career Allow Rate
13 granted / 69 resolved
-51.2% vs TC avg
Strong +37% interview lift
Without
With
+36.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 7m
Avg Prosecution
41 currently pending
Career history
110
Total Applications
across all art units

Statute-Specific Performance

§101
16.1%
-23.9% vs TC avg
§103
39.8%
-0.2% vs TC avg
§102
13.8%
-26.2% vs TC avg
§112
28.4%
-11.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 69 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 2-9, 280-291, and 294 are rejected under 35 U.S.C. 103 as being unpatentable over Cole et al. (US 20190000360 A1 – previously cited), referred to as Cole hereinafter, in view of Raisoni et al. (US 20180228408), hereinafter Raisoni, and Harper et al. (US 20110193704 A1 – previously cited) referred to as Harper hereinafter. Regarding claim 5, Cole teaches an analyte monitoring system (see ABSTRACT), comprising: a sensor control device comprising an analyte sensor, wherein at least a portion of the analyte sensor is configured to be in fluid contact with a bodily fluid of a subject (¶ [0022,0025], an in vivo analyte sensor for contacting bodily fluid of the subject is part of an on-body device (OBD) referred to as the sensor control device hereinafter); and a reader device (¶ [0026], reader device used to analyze information from the sensor data), comprising: wireless communication circuitry configured to receive a current sensor reading from the sensor control device (¶ [0030], sensor control device communicates with the reader device wirelessly); and one or more processors coupled to a memory, the memory storing instructions that, when executed by the one or more processors (¶ [0050] and fig. 2), cause the one or more processors to: determine a time elapsed since the current sensor reading was received (¶ [0103], the reader device executes data synchronization between sensor control device by determining if there has been a time elapsed since the current sensor reading was received during one or more successive receiving windows), determine whether the time elapsed exceeds a signal loss indicator threshold (¶ [0101-0103], the reader device determines when the time elapsed exceeds a communication interval (CI) and/or receiving window referred to hereinafter as the signal loss threshold), in response to a determination that the time elapsed exceeds the signal loss indicator threshold, generate a signal loss indicator (¶ [0103], once the reader device confirms loss of synchronization, a signal loss indicator is generated in the form of an audible, visual, and/or tactile notification). Cole fails to teach display an analyte trend graph and a numeric analyte level and trend arrow indicator, wherein the numeric analyte level and trend arrow indicator is displayed above the analyte trend graph. Raisoni teaches an analyte monitoring system with a patient application and display (abstract). The system is configured to display an analyte level and trend arrow above the analyte trend graph (¶[0093] and fig. 14A). Therefore, it would have been obvious to one of ordinary skill in the art at the time the invention was effectively filed to have modified the device of Col, such that an numeric analyte level and trend arrow indicator is displayed above the analyte trend graph, as taught by Raisoni, to aid in providing an inclusive platform of the user’s physiological information for further monitoring. Cole fails to teach determining whether the current sensor reading is invalid, and in response to a determination that the current sensor reading is invalid, generating an invalid sensor reading indicator, and preventing display of numeric analyte level and trend arrow indicator by displaying non-alphanumeric characters in place of the numeric analyte level above the analyte trend graph. Harper teaches an analyte monitoring device (see abstract and para. [0053]) comprising a processor (¶ [0058]) configured to determine whether current blood glucose result is settling and glucose results may not be accurate (invalid) and/or other alert determination criteria and generating an invalid sensor reading indicator on a display based on the determination of an alert criteria (¶ [0251-252]). The generated alert indicator displayed prevents display of numeric analyte level and trend arrow indicator and upon user interaction/intervention the user can be returned to a home screen (¶ [0261-262] figs. 2A,3A and 20-21). The display of analyte levels can be replaced with nonalphanumeric characters such as, icon, video clip, sound byte, etc. (¶ [0261], “Although text is specifically shown in FIG. 20, it is contemplated that the text may be replaced by an icon, a series of icons, video clip, sound byte etc.”). Additionally, Harper discloses “information mode home screen 300 may also include system information icons on a portion or panel of the information mode home screen 300. In certain embodiments, the system information icons indicate the status of various system components. Such icons may include a wireless connection icon 330, an audio/vibratory settings icon 332, a calibration status icon 334, and battery icon 336. Although not shown, other icons may be displayed including a sensor life icon that shows the remaining life of a sensor, such as, for example, sensor 101 or an alarm notification icon indicating that an alarm or alert condition is detected.” indicating that the display screen can comprise a plurality of panels that can depict a variety of information, e.g., trend graph, alert message, etc., and arrange them per user preference, e.g., alert above graph, etc. (¶ [0107,0233-235] and figs 3A-3C). In support, Raisoni’s trend graph screen that comprises the trend arrow and glucose level above the trend line can be other “items and features” including alert icons (¶[0093] and Table 1). Therefore, it would have been obvious to one of ordinary skill in the art at the time the invention was effectively filed to have modified the system of Cole-Raisoni, such that an invalid sensor reading indicator is generated based on an invalid sensor reading by displaying non-alphanumeric characters in place of the numeric analyte level above the analyte trend graph, as taught by Harper, to aid in notifying a user when current signal readings are invalid and to recommend actions that will generate valid glucose readings (¶ [0252-253] of Harper). Additionally, it would have been obvious to one of ordinary skill in the art at the time the invention was effectively filed to have rearranged the non-alphanumeric characters above the analyte trend graph as it would not have modified the operation of the device and is an obvious matter of design choice (see MPEP 2144.04 IV. C). Regarding claim 287, Cole teaches an analyte monitoring system (see ABSTRACT), comprising: a sensor control device comprising an analyte sensor, wherein at least a portion of the analyte sensor is configured to be in fluid contact with a bodily fluid of a subject (¶ [0022,0025], an in vivo analyte sensor for contacting bodily fluid of the subject is part of an on-body device (OBD) referred to as the sensor control device hereinafter); and a reader device (¶ [0026], reader device used to analyze information from the sensor data), comprising: wireless communication circuitry configured to receive a current sensor reading from the sensor control device (¶ [0030], sensor control device communicates with the reader device wirelessly); and one or more processors coupled to a memory, the memory storing instructions that, when executed by the one or more processors (¶ [0050] and fig. 2), cause the one or more processors to: determine a time elapsed since the current sensor reading was received (¶ [0103], the reader device executes data synchronization between sensor control device by determining if there has been a time elapsed since the current sensor reading was received during one or more successive receiving windows), determine whether the time elapsed exceeds a signal loss indicator threshold (¶ [0101-0103], the reader device determines when the time elapsed exceeds a communication interval (CI) and/or receiving window referred to hereinafter as the signal loss threshold), in response to a determination that the time elapsed exceeds the signal loss indicator threshold, generate a signal loss indicator (¶ [0103], once the reader device confirms loss of synchronization, a signal loss indicator is generated in the form of an audible, visual, and/or tactile notification), in response to a determination that the time elapsed does not exceed a signal loss indicator threshold, measurements will continue to be received (¶ [0074-76,80-82]). Cole fails to teach display an analyte trend graph and a numeric analyte level and trend arrow indicator, wherein the numeric analyte level and trend arrow indicator is displayed above the analyte trend graph. Raisoni teaches an analyte monitoring system with a patient application amd display (abstract). The system is configured to display an analyte level and trend arrow above the analyte trend graph (¶[0093] and fig. 14A). Therefore, it would have been obvious to one of ordinary skill in the art at the time the invention was effectively filed to have modified the device of Col, such that an numeric analyte level and trend arrow indicator is displayed above the analyte trend graph, as taught by Raisoni, to aid in providing an inclusive platform of the user’s physiological information for further monitoring. Cole fails to teach determining whether the current sensor reading is invalid, and in response to a determination that the current sensor reading is invalid, generating an invalid sensor reading indicator, and preventing display of numeric analyte level and trend arrow indicator, and preventing display of numeric analyte level and trend arrow indicator by displaying non-alphanumeric characters in place of the numeric analyte level above the analyte trend graph. Harper teaches an analyte monitoring device (see abstract and para. [0053]) comprising a processor (¶ [0058]) configured to determine whether current blood glucose result is settling and glucose results may not be accurate (invalid) and/or other alert determination criteria and generating an invalid sensor reading indicator on a display based on the determination of an alert criteria (¶ [0251-252]). The generated alert indicator displayed prevents display of numeric analyte level and trend arrow indicator and upon user interaction/intervention the user can be returned to a home screen (¶ [0261-262] figs. 2A,3A and 20-21). The display of analyte levels can be replaced with nonalphanumeric characters such as, icon, video clip, sound byte, etc. (¶ [0261], “Although text is specifically shown in FIG. 20, it is contemplated that the text may be replaced by an icon, a series of icons, video clip, sound byte etc.”). In support, Raisoni’s trend graph screen that comprises the trend arrow and glucose level above the trend line can be other “items and features” including alert icons (¶[0093] and Table 1). Therefore, it would have been obvious to one of ordinary skill in the art at the time the invention was effectively filed to have modified the system of Cole, such that an invalid sensor reading indicator is generated based on an invalid sensor reading by displaying non-alphanumeric characters in place of the numeric analyte level above the analyte trend graph, as taught by Harper, to aid in notifying a user when current signal readings are invalid and to recommend actions that will generate valid glucose readings (¶ [0252-253] of Harper). Additionally, it would have been obvious to one of ordinary skill in the art at the time the invention was effectively filed to have rearranged the non-alphanumeric characters above the analyte trend graph as it would not have modified the operation of the device and is an obvious matter of design choice (see MPEP 2144.04 IV. C). Regarding claim 2, Cole teaches wherein the signal loss indicator threshold is five minutes (¶ [0075-76,0080,0103], the analyte monitoring system is configured to collect analyte measurements in successive intervals and/or communication intervals, wherein the processor is configured to determine when no transmission has been detected during a successive interval and/or communication interval which can be every five minutes(threshold), and output a notification to the user when the synchronous link has been lost or enter a procedure to reestablish synchronization). Regarding claim 3, Cole teaches wherein the reader device is a smart phone (¶ [0049], the reader device is a smart phone). Regarding claim 4, Cole teaches wherein the processor is configured to output the signal loss indicator as a signal loss message to a display of the reader device (¶ [0071,0080], " the transmitted alarm indication can specify whether the alarm is related to an analyte measurement or some other factor" and "If no transmission is received at the Xth transmission time then reader 120 can determine that the synchronous link has been lost and generate a notification" indicating that when synchronization is lost, the device will output an alarm/notification on the display of the reader device to inform the user). Regarding claims 6 and 288, Harper teaches wherein the invalid sensor reading indicator is a sensor error indicator or a temperature error indicator (¶ [0251-252], the display outputs a sensor indicator when there is a problem with the test strip or analyte monitoring device e.g., sensor and a temperature error indicator based on skin or sensor temperature). Regarding claims 7 and 289, Harper teaches wherein the temperature error indicator is based on a temperature measurement obtained by the sensor control device (¶ [0235,0251], the error is based on a temperature measurement of the skin or sensor obtained by the analyte monitoring device/sensor control device). Regarding claims 8 and 290, Harper teaches wherein the sensor error indicator is based on an early signal attenuation detected by the sensor control device (¶ [0108,0251], signal strength/attenuation can be determined and based on the determination, a notification can be generated to indicate that the sensor signal is settling, glucose measurement is inaccurate, and/or the system requires another measurement). Regarding claims 9 and 291, Cole-Raisoni fail to teach wherein the processor is configured to display a valid current sensor reading in response to a determination that the current sensor reading is not invalid. Harper teaches wherein the processor is configured to display a valid current sensor reading in response to a determination that the current sensor reading is not invalid (¶ [0048], the analyte monitoring device displays valid current sensor readings when alert conditions are not detected). It would have been obvious to one of ordinary skill in the art at the time the invention was effectively filed to have modified the device of Cole-Raisoni-Harper, such that a valid sensor reading is displayed, as taught by Harper to accurately output a severity of a condition that the system state information and the user state information represents (¶ [0084]). Regarding claim 280, Cole teaches the analyte monitoring system uses Bluetooth (¶ [0034]) and Harper teaches wherein the invalid sensor reading indicator is a Bluetooth Off indicator (¶ [0108,0251] of Harper, "when a connection has not been established between the transmitter and the analyte monitoring device 200 [sensor], a second form of the wireless connection icon 330 is output on the display to indicate a connection has not been established" and "CGM not available. Connect to Sensor."--indicating that the analyte monitoring device has not been receiving signals sent by the transmitter" indicates that the invalid sensor reading is a Bluetooth Off Indicator). Regarding claim 281, Harper teaches wherein the Bluetooth Off indicator indicates that a Bluetooth transmitter of the reader device is disabled or switched off (¶ [0108,0061], the bluetooth off indicator indicates when the connection between the bluetooth transmitter of the analyte monitoring device/reading device is not established indicating that it can be disabled or switched off). Regarding claim 282, Harper teaches wherein the temperature error indicator is a Sensor Too Hot indicator (¶ [0251], the temperature error is a Sensor/Analyte monitoring device too hot indicator output on display of the analyte monitoring device). Regarding claim 283, Harper teaches wherein the temperature error indicator is a Sensor Too Cold indicator (¶ [0251], the temperature error is a Sensor/Analyte monitoring device too cold indicator output on display of the analyte monitoring device). Regarding claim 284, Harper teaches wherein the temperature error indicator indicates an error based on the temperature of the sensor (¶ [0251], "calibration failed because the analyte monitoring device was too warm or too cold"). Regarding claim 285, Harper teaches wherein the temperature error indicator indicated an error based on the temperature of skin (¶ [0251], a message indicating " the skin to cold or too warm to display continuous glucose readings and that glucose alarms are not active" is output as the temperature error indicator). Regarding claim 286, Harper teaches wherein the processor is configured to display an informational window with information related to the invalid sensor reading indicator (¶ [0251], depending on which alert criteria is met, the analyte monitoring system outputs to a display information regarding the alert, e.g., when too hot or too cold, battery level when low, when communication is lost with the transmitter). Regarding claim 294, Cole- Raisoni fail to teach wherein the instructions, when executed by the one or more processors, further cause the one or more processors to display an information icon in response to the determination that the current sensor reading is invalid, and display an informational window with information related to the invalid sensor reading indicator when the information icon is pressed. Harper teaches “In certain embodiments, the user may acquire additional information regarding the alarm or event such as analyte levels, insulin bolus administered, meal intake details and activities and the like by selecting one of the notification icons 470” (emphasis added) indicating that information icon representing an alarm condition/alarm can be displayed and selected on to provide additional information(¶ [0125]). It would have been obvious to one of ordinary skill in the art at the time the invention was effectively filed to have modified the device of Cole- Raisoni-Harper, such that display an information icon in response to the determination that the current sensor reading is invalid, and display an informational window with information related to the invalid sensor reading indicator when the information icon is pressed, as taught by Harper, to aid the user in acquiring additional information, e.g., current, retrospective, and/or historical, regarding the alarm or event (¶ [0125]). Response to Arguments Applicant's arguments filed 01/20/2026 have been fully considered but they are not fully persuasive. Applicant’s arguments with respect to amendments of independent claims 5 and 294 have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Raisoni teaches a high analyte alarm level, a low analyte alarm level, an analyte high target level, an analyte low target level, a current analyte level, a connection status, a trend arrow, a trend graph, and a profile; and, simultaneously displaying, on a display device electronically coupled to the analyte monitoring device, one or more interactive graphical control elements and the plurality of information items. US 20160345874 Amerson teaches a code having the ability to save and recall data, view at-a-glance glucose measurements in real-time (highs and lows), alarms for meals or snacks, easy-to-read recommendations, arrows showing trends of the user's blood glucose levels, scroll-though graphs for patterns of the user's blood glucose level, customizable predictive alerts for oncoming highs and lows by flashing icons or audible alarms (even if the device is set to a vibrate only mode), telecommunication updates, emergency related information, automated 911 calling, and the like. US 20150112170 Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to MARTIN NATHAN ORTEGA whose telephone number is (571)270-7801. The examiner can normally be reached M-F 7:10 am - 5:00 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Robert (Tse) Chen can be reached at (571) 272-3672. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MARTIN NATHAN ORTEGA/Examiner, Art Unit 3791 /TSE W CHEN/Supervisory Patent Examiner, Art Unit 3791
Read full office action

Prosecution Timeline

Sep 17, 2021
Application Filed
Apr 26, 2022
Response after Non-Final Action
Nov 02, 2023
Non-Final Rejection — §103
Feb 08, 2024
Response Filed
May 15, 2024
Final Rejection — §103
Jul 26, 2024
Request for Continued Examination
Jul 29, 2024
Response after Non-Final Action
Aug 19, 2024
Non-Final Rejection — §103
Jan 29, 2025
Response Filed
Apr 08, 2025
Final Rejection — §103
Jun 16, 2025
Response after Non-Final Action
Jul 10, 2025
Request for Continued Examination
Jul 12, 2025
Response after Non-Final Action
Jul 16, 2025
Non-Final Rejection — §103
Jan 14, 2026
Applicant Interview (Telephonic)
Jan 14, 2026
Examiner Interview Summary
Jan 20, 2026
Response Filed
Apr 03, 2026
Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12551119
BLOOD PRESSURE MEASUREMENT DEVICE
2y 5m to grant Granted Feb 17, 2026
Patent 12426860
DUAL LUMEN COAXIAL INTRODUCER HAVING INTEGRATED TISSUE MARKER DELIVERY
2y 5m to grant Granted Sep 30, 2025
Patent 12383193
SKIN INSPECTION DEVICE FOR IDENTIFYING ABNORMALITIES
2y 5m to grant Granted Aug 12, 2025
Patent 12005014
Assembly, Configured to Detect a Body on a Support
2y 5m to grant Granted Jun 11, 2024
Patent 11826145
TAIL PRESSING TYPE DISPOSABLE SAFETY LANCET
2y 5m to grant Granted Nov 28, 2023
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

7-8
Expected OA Rounds
19%
Grant Probability
56%
With Interview (+36.8%)
3y 7m
Median Time to Grant
High
PTA Risk
Based on 69 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month